11-64556141-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP6BS2
The NM_018484.4(SLC22A11):c.142C>T(p.Arg48*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0041 in 1,614,162 control chromosomes in the GnomAD database, including 22 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.0027 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0042 ( 18 hom. )
Consequence
SLC22A11
NM_018484.4 stop_gained
NM_018484.4 stop_gained
Scores
2
3
2
Clinical Significance
Conservation
PhyloP100: 1.92
Genes affected
SLC22A11 (HGNC:18120): (solute carrier family 22 member 11) The protein encoded by this gene is involved in the sodium-independent transport and excretion of organic anions, some of which are potentially toxic. The encoded protein is an integral membrane protein and is found mainly in the kidney and in the placenta, where it may act to prevent potentially harmful organic anions from reaching the fetus. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP6
Variant 11-64556141-C-T is Benign according to our data. Variant chr11-64556141-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 3038511.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High Homozygotes in GnomAd4 at 4 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC22A11 | NM_018484.4 | c.142C>T | p.Arg48* | stop_gained | 1/10 | ENST00000301891.9 | NP_060954.1 | |
SLC22A11 | XM_011545167.2 | c.-154C>T | 5_prime_UTR_premature_start_codon_gain_variant | 1/9 | XP_011543469.1 | |||
SLC22A11 | NM_001307985.2 | c.142C>T | p.Arg48* | stop_gained | 1/8 | NP_001294914.1 | ||
SLC22A11 | XM_011545167.2 | c.-154C>T | 5_prime_UTR_variant | 1/9 | XP_011543469.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00267 AC: 407AN: 152160Hom.: 4 Cov.: 32
GnomAD3 genomes
AF:
AC:
407
AN:
152160
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00288 AC: 725AN: 251470Hom.: 4 AF XY: 0.00283 AC XY: 385AN XY: 135918
GnomAD3 exomes
AF:
AC:
725
AN:
251470
Hom.:
AF XY:
AC XY:
385
AN XY:
135918
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00425 AC: 6211AN: 1461884Hom.: 18 Cov.: 31 AF XY: 0.00408 AC XY: 2966AN XY: 727242
GnomAD4 exome
AF:
AC:
6211
AN:
1461884
Hom.:
Cov.:
31
AF XY:
AC XY:
2966
AN XY:
727242
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00267 AC: 407AN: 152278Hom.: 4 Cov.: 32 AF XY: 0.00254 AC XY: 189AN XY: 74460
GnomAD4 genome
AF:
AC:
407
AN:
152278
Hom.:
Cov.:
32
AF XY:
AC XY:
189
AN XY:
74460
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
21
ALSPAC
AF:
AC:
30
ESP6500AA
AF:
AC:
5
ESP6500EA
AF:
AC:
32
ExAC
AF:
AC:
316
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
SLC22A11-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 08, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at